본문 바로가기
KERD
논문KCI 등재

첨단 암 치료로서 중입자치료의 임상적 유용성에 대한 고찰

Literature Review of Clinical Usefulness of Heavy Ion Particle as an New Advanced Cancer Therapy

최상규
대한방사선과학회 (Korean Society of Radiological Science)|2019.12|Journal of Radiological Science and Technology|제42권 제6호|pp. 413-422

4

조회

0

다운로드

6

인용

0

참고문헌

키워드

방사선치료브래그 피크Bragg peak탄소이온중이온 입자양성자Carbon ionHeavy ion particleRadiotherapyProton
주제분류방사선과학

초록

Heavy ion particle, represented carbon ion, radiotherapy is currently most advanced radiation therapy technique. Conventional radiation therapy has made remarkable changes over a relatively short period of time and leading various developments such as intensity modulated radiation therapy, 4D radiation therapy, image guided radiation therapy, and high precisional therapy. However, the biological and physical superiority of particle radiation, represented by Bragg peak, can give the maximum dose to tumor and minimal dose to surrounding normal tissues in the treatment of cancers in various areas surrounded by radiation-sensitive normal tissues. However, despite these advantages, there are some limitations and factors to consider. First, there is not enough evidence, such as large-scale randomized, prospective phase III trials, for the clinical application. Secondly, additional studies are needed to establish a very limited number of treatment facilities, uncertainty about the demand for heavy particle treatment, parallel with convetional radiotherapy or indications. In addition, Bragg peak of the heavy particles can greatly reduce the dose to the normal tissues front and behind the tumor compared to the photon or protons. High precision and accuracy are needed for treatment planning and treatment, especially for lungs or livers with large respiratory movements. Currently, the introduction of the heavy particle therapy device is in progress, and therefore, it is expected that more research will be active.

Abstract

Heavy ion particle, represented carbon ion, radiotherapy is currently most advanced radiation therapy technique. Conventional radiation therapy has made remarkable changes over a relatively short period of time and leading various developments such as intensity modulated radiation therapy, 4D radiation therapy, image guided radiation therapy, and high precisional therapy. However, the biological and physical superiority of particle radiation, represented by Bragg peak, can give the maximum dose to tumor and minimal dose to surrounding normal tissues in the treatment of cancers in various areas surrounded by radiation-sensitive normal tissues. However, despite these advantages, there are some limitations and factors to consider. First, there is not enough evidence, such as large-scale randomized, prospective phase III trials, for the clinical application. Secondly, additional studies are needed to establish a very limited number of treatment facilities, uncertainty about the demand for heavy particle treatment, parallel with convetional radiotherapy or indications. In addition, Bragg peak of the heavy particles can greatly reduce the dose to the normal tissues front and behind the tumor compared to the photon or protons. High precision and accuracy are needed for treatment planning and treatment, especially for lungs or livers with large respiratory movements. Currently, the introduction of the heavy particle therapy device is in progress, and therefore, it is expected that more research will be active.

참고문헌 (52)

  1. Choi SG, "Recent advances in radiotherapy", Korean J Clin Geri, 9(2), pp.218~224 (2008)
  2. Wilson RR, "Radiological use of fast protons", Radiology, 47, pp.487~491 (1946)
  3. Allen C, "Heavy charged particle radiobiology : Using enhanced biological effectiveness and improved beam focusing to advance cancer therapy", Mutat Res, 711, pp.150~157 (2011)
  4. Jereczek-Fossa BA, "Particle beam radiotherapy for head and neck tumors : Radiobiological basis and clinical experience", Head Neck, 28, pp.750~760 (2006)
  5. Jermann M, "Particle therapy statistics in 2014", Int J Part Ther, 2, pp.50~54 (2015)
  6. "Particle Therapy Patient Statistics (per end of 2015)"[URL]
  7. Johns HE, "The physics of radiology", pp.133~166 (1983), Charles C Thomas Publisher
  8. Lutz W, "Stereotactic radiosurgery", pp.7~15 (1993), McGrawHill
  9. Mohan R, "Proton therapy—Present and future", Adv Drug Deliv Rev, 109, pp.26~44 (2017)
  10. Bragg W, "On the ionization of various gases by the alpha particles of radium", Proc Phys Soc Lond, pp.523~550 (1907)
  11. De Laney T, "Proton and Charged Particle Radiotherapy" (2007), Lippincott, Williams and Wilkins
  12. Antony J. Lomax, "Charged Particle Therapy: The Physics of Interaction", The Cancer Journal, 15(4), pp.285~291 (2009), Ovid Technologies (Wolters Kluwer Health)[DOI]
  13. Uzawa A, "Comparison of biological effectiveness of carbon-ion beams in Japan and Germany", Int J Radiat Oncol Biol Phys, 73, pp.1545~1551 (2009)
  14. Radhe Mohan, "Proton therapy – Present and future", Advanced Drug Delivery Reviews, 109, pp.26~44 (2017), Elsevier BV[DOI]
  15. Weyrather WK, "Particle beams for cancer therapy", Clin Oncol (R Coll Radiol), 15(1), pp.S23~S28 (2003)
  16. Hall E, "Radiobiology for the radiologist" (2012), Lippincott Williams & Wilkins
  17. Uli Weber, "Comparison of Carbon Ions Versus Protons", The Cancer Journal, 15(4), pp.325~332 (2009), Ovid Technologies (Wolters Kluwer Health)[DOI]
  18. Schulz-Ertner D, "Carbon ion radiotherapy of skull base chondrosarcomas", Int J Radiat Oncol Biol Phys, 67, pp.171~177 (2007)
  19. Mizoe JE, "Results of carbon ion radiotherapy for head and neck cancer", Radiother Oncol, 103, pp.32~37 (2012)
  20. Yanagi T, "Mucosal malignant melanoma of the head and necktreated by carbon ion radiotherapy", Int J Radiat Oncol Biol Phys, 74, pp.15~20 (2009)
  21. Mizoe J, "Carcon ion radiotherapy for skull base chordoma", Skull Base, 19, pp.219~224 (2009)
  22. Matthias Uhl, "Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: First long-term results", Cancer, 120(21), pp.3410~3417 (2014), Wiley[DOI]
  23. Masashi Koto, "Risk factors for brain injury after carbon ion radiotherapy for skull base tumors", Radiotherapy and Oncology, 111(1), pp.25~29 (2014), Elsevier BV[DOI]
  24. Thomas Held, "Carbon Ion Reirradiation for Recurrent Head and Neck Cancer: A Single-Institutional Experience", International Journal of Radiation Oncology*Biology*Physics, 105(4), pp.803~811 (2019), Elsevier BV[DOI]
  25. Noriyoshi Sawabata, "Japanese Lung Cancer Registry Study of 11,663 Surgical Cases in 2004: Demographic and Prognosis Changes Over Decade", Journal of Thoracic Oncology, 6(7), pp.1229~1235 (2011), Elsevier BV[DOI]
  26. Lamberto Widesott, "Proton therapy in lung cancer: Clinical outcomes and technical issues. A systematic review", Radiotherapy and Oncology, 86(2), pp.154~164 (2008), Elsevier BV[DOI]
  27. Aaron M. Allen, "An evidence based review of proton beam therapy: The report of ASTRO’s emerging technology committee", Radiotherapy and Oncology, 103(1), pp.8~11 (2012), Elsevier BV[DOI]
  28. Iwata H, "High-dose protontherapy and carbon-ion therapy for stage I nonsmall cell lungcancer", Cancer, 116(10), pp.2476~2485 (2010)
  29. Fujii O, "A retrospective comparison of proton therapy and carbon ion therapy for stageI non-small cell lung cancer", Radiotherapy and Oncology, 109(1), pp.32~37 (2013)
  30. Miyamoto T, "Curative treatmentof Stage I non-small-cell lung cancer with carbon ion beamsusing a hypofractionated regimen", Int J Radiat Oncol Biol Phys, 67(3), pp.750~758 (2007)
  31. Grutters JP, "Comparison ofthe effectiveness of radiotherapy with photons, protons andcarbon-ions for non-small cell lung cancer : A meta-analysis", Radiotherapy and Oncology, 95(1), pp.32~40 (2010)
  32. Segawa Y, "Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomy-cin, vindesine, and cisplatin combination chemotherapy with con-current thoracic radiotherapy in locally advanced non–small-cell lung cancer : OLCSG 0007", J Clin Oncol, 28(20), pp.3299~3306 (2010)
  33. Bradley JD, "Standard-dose versus high-dose conformal radiotherapy with concurrent and consoli-dation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer(RTOG 0617) : A randomised, two-by-two factorial p", Lancet Oncol, 16(2), pp.187~199 (2015)
  34. Atagi S, "Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: A randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)", Lancet Oncol, 13(7), pp.671~678 (2012)
  35. Samir Sejpal, "Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer", Cancer, 117(13), pp.3004~3013 (2011), Wiley[DOI]
  36. Melissa A.L. Vyfhuis, "Advances in proton therapy in lung cancer", Therapeutic Advances in Respiratory Disease, 12 (2018), SAGE Publications[DOI]
  37. Karube M, "Carbon-ion radiother-apy for patients with advanced stage non–small-cell lung cancer at multicenters", J Radiat Res, 58(5), pp.761~764 (2017)
  38. Kazuhiko Hayashi, "Clinical outcomes of carbon‐ion radiotherapy for locally advanced non‐small‐cell lung cancer", Cancer Science, 110(2), pp.734~741 (2018), Wiley[DOI]
  39. Hong TS, "Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head", Int J Radiat Oncol Biol Phys, 79, pp.151~157 (2011)
  40. Sachsman S, "Proton therapy and concomitant capecitabine for nonmetastatic unresectable pancreatic adenocarcinoma", Int J Particle Ther, 1, pp.692~701 (2014)
  41. Okada T, "Carbon ion radiotherapy : Clinical experiences at National Institute of Radiological Science(NIRS)", J Radiat Res, 51, pp.355~364 (2010)
  42. Shinoto M, "Phase 1 trial of preoperative, short-course carbon-ion radiotherapy for patients with resectable pancreatic cancer", Cancer, 119, pp.45~51 (2013)
  43. Shohei Kawashiro, "Multi-institutional Study of Carbon-ion Radiotherapy for Locally Advanced Pancreatic Cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1403 Pancreas", International Journal of Radiation Oncology*Biology*Physics, 101(5), pp.1212~1221 (2018), Elsevier BV[DOI]
  44. Zietman AL, "Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate : Long-term results from proton radiation oncology group", american college of radiology 95-09, 2010, pp.303, 1046~1053
  45. Schulte RW, "Value and perspectives of proton radiation therapy for limited stage prostate cancer", Strahlenther Onkol, 176, pp.3~8 (2000)
  46. Nihei K, "Multi-institutional phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities", Int J Radiat Oncol Biol Phys, 81, pp.390~396 (2011)
  47. Takagi M, "Long-term outcomes in patients treated with proton therapy for localized prostate cancer", Cancer Med, 6, pp.2234~2243 (2017)
  48. Nomiya T, "A multi-institutional analysis of prospective studies of carbon ion radiotherapy for prostate cancer: A report from the Japan Carbon ion Radiation Oncology Study Group (J-CROS)", Radiother Oncol, 121, pp.288~293 (2016)
  49. Ishikawa H, "Carbon-ion radiation therapy for prostate cancer", Int J Urol, 19, pp.296~305 (2012)
  50. Ishikawa H, "Carbon-ion Radiotherapy for Prostate Cancer : Analysis ofMorbidities and Change in Health-related Quality of Life", Anticancer Research, 35, pp.5559~5566 (2015)
  51. 송관수, "전립선암에 대한 토모치료와 양성자치료의 치료계획 비교", 방사선기술과학, 36(1), pp.31~38 (2013), 대한방사선과학회
  52. 김정수, "소아암 환자의 양성자치료 시 DIPS 촬영에 따른 피폭선량", 방사선기술과학, 34(1), pp.59~64 (2011), 대한방사선과학회

관련 논문AI추천

Who Will Benefit from Charged-Particle Therapy?김경수, 우홍균대한암학회 · Cancer Research and Treatment2021 · 제53권 제3호Physical and Biological Characteristics of Particle Therapy for Oncologists금웅섭, 김용배, 김진성, 변화경, 양경미, 유규상, 한민철대한암학회 · Cancer Research and Treatment2021 · 제53권 제3호Technological Advances in Charged-Particle Therapy김정인, 박종민, 우홍균대한암학회 · Cancer Research and Treatment2021 · 제53권 제3호Effectiveness and Safety of Carbon Ion Radiotherapy in Solid Tumors: A Systematic Review and Meta-Analysis김수진, 박근영, 윤지은, 이월숙연세대학교의과대학 · Yonsei Medical Journal2024 · 제65권 제6호Carbon ion radiotherapy in the treatment of hepatocellular carcinoma변화경, 성진실, Changhwan Kim대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제4호Carbon-ion radiotherapy in osteosarcoma of the mandible: a case report김동욱, 김형준, 윤민영, 하태욱, Park Slmaro대한구강악안면외과학회 · 대한구강악안면외과학회지2021 · 제47권 제4호

이 간행물의 다른 논문 (12건)

슬대퇴관절의 Merchant View에서 중심 X선 위치에 따른 일치각 평가최재호, 주영철, 임우택, 김현진pp. 423-428진단용 X선을 이용한 방사선검사에서 차폐체 모양과 부가필터 변화에 따른 난소의 선량 분석최준호pp. 429-434혈관조영장비의 테이블-피사체간 거리 변화에 따른 혈관측정 정확도 연구김승기pp. 435-4403D 프린팅 기법 기반의 Hoffman Brain 팬텀 개발 및 유용성 평가이주영, 박훈희pp. 441-446전자선치료 시 3D 프린터로 제작한 환자 맞춤형 차폐체의 유용성 평가서태석, 안기송, 정우찬, 윤도균, 김대현, 김무섭, 심재구pp. 447-454
원문 보기